Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
about
The Role of End-of-Life Issues in the Design and Reporting of Cancer Clinical Trials: A Structured Literature ReviewHealth-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trialThe impact of quality-of-life data in relative effectiveness assessments of new anti-cancer drugs in European countriesElectronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer Patients.Outcomes Assessment After Hand Burns.Evaluation of health status in patients with hepatitis c treated with and without interferon.
P2860
Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Informative value of Patient R ...... h Technology Assessment (HTA).
@en
Informative value of Patient Reported Outcomes
@nl
type
label
Informative value of Patient R ...... h Technology Assessment (HTA).
@en
Informative value of Patient Reported Outcomes
@nl
prefLabel
Informative value of Patient R ...... h Technology Assessment (HTA).
@en
Informative value of Patient Reported Outcomes
@nl
P356
P1476
Informative value of Patient R ...... h Technology Assessment (HTA).
@en
P2093
Dagmar Lühmann
Heiner Raspe
P356
10.3205/HTA000092
P577
2011-02-02T00:00:00Z